BioSpace News Archive

Esri Chief Scientist Will Discuss the Book Women and GIS: Mapping Their Stories

According to the Census Bureau, the elderly population will double between now and 2050, with one in five Americans considered elderly.

Liberty Health Sciences Inc. announced that it will be holding a grand opening celebration on Tuesday, February 19 from 10 a.m. to 7 p.m. for its new dispensary opening in North Miami, and increasing the number of the Company’s dispensaries in Miami to two, and in the state of Florida to nine.

To get the job done they offer direct access to famed mesothelioma attorney Erik Karst, founding partner of the law firm Karst von Oiste one of the nation’s premier mesothelioma and asbestos exposure law firms.

IDEAYA Biosciences, Inc., an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics to treat cancer, announced the appointments of Frank McCormick, Ph.D., FRS, and William Sellers, M.D., to its Scientific Advisory Board.

Many of the nearly 7,000 rare diseases identified by the US National Institutes of Health (NIH) affect the functioning of the digestive tract.

Cerus Corporation (Nasdaq:CERS) announced today that its fourth quarter and full-year 2018 results will be released on Tuesday, February 26, 2019, after the close of the stock market.

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the launch of IntelliSpace Cardiovascular 4.1, its next-generation cardiovascular image and information management system.

Special Olympics athletes and advocates from across the United States converged on Capitol Hill in Washington D.C. on Feb 12th for Special Olympics’ annual “Capitol Hill Day”

CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical research and development company specializing in oncology, and its private, wholly-owned subsidiary Centurion BioPharma Corporation, today announced the publication of peer reviewed, scientific research for LADR-7 (AE-Keto-Sulf07), one of its lead LADR™ (Linker Activated Drug Release) candidates.